T. Tan
Impact in
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
- Toxicology top 5%
Papers in
-
- Cardiovascular Function and Risk Factors 4
- Cardiomyopathy and Myosin Studies 2
-
- Spondyloarthritis Studies and Treatments 2
- Rheumatoid Arthritis Research and Therapies 2
- Co-authors
- Bernard Yu‐Hor Thong (5 shared papers)Joseph H. Burchenal (2 shared papers)M. Lois Murphy (2 shared papers)David A. Karnofsky (2 shared papers)Marguerite P. Sykes (2 shared papers)Rose Ruth Ellison (2 shared papers)C. P. Rhoads (1 shared paper)Harold W. Dargeon (1 shared paper)
- Journals
- Open Forum Infectious Diseases (2 papers)European Heart Journal (2 papers)British Journal of Clinical Pharmacology (1 paper)Blood (1 paper)Annals of the New York Academy of Sciences (1 paper)
- Partner nations
- SingaporeAustraliaUnited States
In The Last Decade
T. Tan
30 papers receiving 734 citations
T. Tan's Hit Papers
Peers
Comparison fields: 5 of 94
- Pharmacology 233
- Toxicology 41
- Immunology and Allergy 67
- Rheumatology 117
- Dermatology 66
Countries citing papers authored by T. Tan
This map shows the geographic impact of T. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Tan more than expected).
Fields of papers citing papers by T. Tan
This network shows the impact of papers produced by T. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Tan. The network helps show where T. Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Evaluation of a New Antimetabolite, 6-Mercaptopurine, in the Treatment of Leukemia and Allied Diseases Hit paper breakdown → | 1953 | 309 |
| 2 | 2010 | 289 | |
| 3 | 2016 | 39 | |
| 4 | 1954 | 35 | |
| 5 | 2021 | 31 | |
| 6 | 2014 | 30 | |
| 7 | 2021 | 20 | |
| 8 | 2005 | 17 | |
| 9 | 2018 | 10 | |
| 10 | 2015 | 9 | |
| 11 | 2019 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2017 | 3 | |
| 19 | Carotid Artery Occlusion in a Patient with Intracranial Rosai-Dorfman Disease | 2003 | 3 |
| 20 | 2023 | 1 |
About T. Tan
T. Tan is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology, Infectious Diseases, Public Health, Environmental and Occupational Health and Pharmacology, having authored 33 papers that have together received 839 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (4 papers), Drug-Induced Adverse Reactions (3 papers), Inflammatory Myopathies and Dermatomyositis (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Contact Dermatitis and Allergies (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cardiomyopathy and Myosin Studies (2 papers). The work is most often cited by research in Pharmacology (233 citations), Toxicology (41 citations), Immunology and Allergy (67 citations), Rheumatology (117 citations) and Dermatology (66 citations). T. Tan has collaborated with scholars based in Singapore, Australia and United States. Frequent co-authors include Bernard Yu‐Hor Thong, Joseph H. Burchenal, M. Lois Murphy, David A. Karnofsky, Marguerite P. Sykes, Rose Ruth Ellison, C. P. Rhoads, Harold W. Dargeon, Louis A. Leone and Lloyd F. Craver. Their work appears in journals such as Open Forum Infectious Diseases, European Heart Journal, British Journal of Clinical Pharmacology, Blood and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.